The activation of AEG-1 in breast cancer cells promotes drug resistance and metastasis [21] and desensitizes hepatoma cells to adriamycin by blocking the ubiquitination and proteasomal degradation of MDR1 [22]. This evidence concerns the gene MTDH and breast carcinoma.